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PVIEWPOINT AND COMMENTARY
Computed Tomographic Angiography
More Than Just a Pretty Picture?
Rita F. Redberg, MD, MSC, FACC
San Francisco, California
There is increased interest in and use of cardiac computed tomographic and magnetic resonance imaging as
the technology continues to improve. We have many small single-center trials on the diagnostic accuracy of
these techniques, but no studies that show a patient benefit from testing. The American College of Cardiology
has recently tackled the “appropriateness challenge” for imaging tests, including computed tomographic and
magnetic resonance imaging. The importance of outcomes data and risks of continuing our investment in com-
puted tomography without outcomes data on benefits for patient care are discussed in this paper. (J Am Coll
Cardiol 2007;49:1827–9) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.09.056t
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iith headlines such as “How New Heart-Scanning Tech-
ology Could Save Your Life” on a recent Time magazine
over (1), and spirited marketing by scanner manufacturers
nd the clinics that use them, it is no wonder that the
olume of cardiac imaging tests is increasing at an exponen-
ial rate. As Oprah Winfrey has shown on national televi-
ion (2), computed tomographic (CT) imaging can take
eautiful pictures, and even create 3-dimensional recon-
tructions of the heart. In light of the explosive growth of
T, it is appropriate to ask whether these pictures lead to
etter patient care and outcomes. In this case, despite the
ssertion of Time that this “new test can prevent heart
ttacks,” there are no data showing that a CT scan (or any
est for that matter) can prevent a heart attack (3).
From 1993 to 2002, the number of cardiac imaging tests
ncreased 26% per year (4). In the same time period,
edicare spending for imaging services paid under the
hysician fee schedule grew over 60%, from $5.7 to $9.3
illion. The volume of CT scans of parts of the body other
han the head increased 82% from 1999 to 2003 per
edicare beneficiary (5). This staggering increase in imag-
ng costs also has attracted a lot of attention, especially from
hose who pay for health care. What value are we getting for
hese expenditures? It is important to know whether these
ncreased expenditures for imaging tests lead to incremental
iagnostic or prognostic information or to improved patient
utcomes.
The increase in cardiac imaging has led to a call for
vidence-based guidance on appropriate use. The American
ollege of Cardiology (ACC), in furtherance of its mission
rom Women’s Cardiovascular Services, School of Medicine, Division of Cardiology,
an Francisco, California.b
Manuscript received August 17, 2006; revised manuscript received October 26,
006, accepted October 30, 2006.o advocate optimal patient care through the development
nd application of clinical practice guidelines, has taken on
his “appropriateness challenge,” as described in an October
005 article by Patel et al. (6). In introducing its appropri-
teness initiative, former ACC President Michael Wolk
xplained that, ideally, criteria for appropriateness should
ncompass “cost effective” and “benefit versus risk” analysis
f available care alternatives, and should be simple, reliable,
alid, and transparent (7). Patel et al. (6) agree that
ppropriateness Criteria (AC) preferably should be based
n high-quality research comparing benefits and risks for
ommon clinical scenarios, but they also recognize that “in the
bsence of ideal evidence,” judgments still must be made.
In deriving its recommendations, the ACC used a
ethod for evaluating appropriateness based on work by
AND, which pioneered “appropriate” methodology in the
990s when it convened expert panels to define appropri-
teness of use of coronary angiography (CA) (8) and
oronary artery bypass grafts (9). Using a similar approach,
he ACC, when necessary, uses expert opinion in lieu of
vidence of benefit when formulating AC. In February of
006, with the expanding use of CT and magnetic reso-
ance (MR) potentially outpacing data showing its clinical
enefit, a committee of the ACC evaluated computed
omography angiography (CTA) under its AC.
Most importantly, we must understand how the data
btained from CTA will change patient management
nd/or lead to better outcomes. There are claims, for
xample, that CTA will act as a gatekeeper and reduce
nvasive angiography rates. However, as of yet, there are no
ata to support this hypothesis. The new AC applied to
TA found that use of cardiac CT/MR for structure and
unction and for diagnosis in symptomatic patients at
ntermediate risk for coronary artery disease is appropriate,
ut repeat testing and general screening uses were viewed
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CT Angiography May 8, 2007:1827–9less favorably (10). Moreover,
because symptomatic patients
with coronary artery disease
probably will be referred to CA
for possible stent placement, it
does not seem likely that CTA
will reduce the number of coro-
nary angiographies.
A major concern is that CTA
instead will be used in asymp-
tomatic, low-risk patients, as
suggested by the Time cover story
and Oprah Winfrey’s show. Be-
fore CTA, this population gen-
rally would not have been (directly) referred for CA.
owever, after a CTA, the portion of this group with
ositive findings, whether true-positive or false-positive,
ery likely will be referred for angiography. For true-positive
esults, patients will get a percutaneous coronary interven-
ion or coronary artery bypass graft, and for false-positive
esults, patients will undergo unnecessary invasive testing.
owever, there currently are no data showing benefits of
evascularization for asymptomatic patients. Indeed, percu-
aneous coronary intervention’s major benefit has been
ymptom relief, which obviously is not relevant for asymp-
omatic patients. Moreover, percutaneous coronary inter-
ention has not been shown to prevent myocardial infarc-
ion or to decrease mortality. Similarly, there have been no
tudies showing the benefit of coronary artery bypass graft-
ng for asymptomatic patients.
Proponents of CTA argue that the latest scanners now
rovide more detail and sharper images than ever. More
nformation, however, even if accurate and more precise, is
ot necessarily better. The real value of any diagnostic
rocedure derives not from its ability to give more informa-
ion, but from whether it suggests a better course of
reatment than the physician would have recommended
nyway. As for CTA, many studies support to some extent
he technology’s accuracy and precision, but do not yet show
hat CT leads to improvement in patient care over better-
tudied noninvasive diagnostic techniques.
The current data on CTA generally involve comparisons
ith CA as the reference standard. Such data on diagnostic
ccuracy are a necessary first step for any new imaging test.
he data on all CTA studies were summarized in the spring
f 2006 by the Duke Evidence-Based Practice Center for
se by the Medicare Coverage Advisory Commission (11).
he investigators note that there were only 4 studies of
oronary CTA with 16-slice CT that prospectively enrolled
ore than 100 patients, all single-center studies. There were
studies of CTA using 64-slice CT, all single-center
tudies and with fewer than 100 patients. In their data
ummary on CTA, the Duke investigators note that the
nalysis by coronary segment showed sensitivity estimates
etween 30% and 99% and specificity estimates between
Abbreviations
and Acronyms
AC  Appropriateness
Criteria
ACC  American College of
Cardiology
CA  coronary angiography
CT  computed
tomography
CTA  computed
tomography angiography
MR  magnetic resonance1% and 98%. The patient level analysis reports sensitivities crom 85% to 100% and specificities between 49% and 98%.
owever, these studies excluded inevaluable segments and
atients with poor quality images from analysis, which
nflated accuracy estimates. In some of the studies, patients
ere prescreened to be sure they could hold their breath for
0 to 25 s before enrollment.
The largest and first multicenter study of multislice CT to
ate was published in July 2006, after the Duke summary
as written. The 11-site, 238-patient study found a high
ercentage of inevaluable scans and false-positive results. Of
,629 nonstented segments evaluated, 427 were inevaluable,
nd there were 96 false-positive results (12). After censoring
ll inevaluable segments as positive, the sensitivity for
etecting more than 70% luminal stenoses was 94%, spec-
ficity 67%, positive predictive value 6%, and negative
redictive value 99% in this study.
Although CTA is noninvasive compared with CA, it is
ot without risks. The estimated radiation dose for a
6-slice CT scan is between 4 and 16.3 mSv depending on
hether electrocardiographic pulsing is used and on the
ender of the patient (radiation doses are higher in women)
13). For 64-slice CT scans, the radiation dose is higher,
etween 4.8 and 21.4 mSv. Comparatively, for CA the
adiation dose is 5.6 mSv (14). There is a risk of nephro-
oxicity from the contrast agent used, and one must consider
hat often it is necessary to administer intravenous beta-
lockade at the time of the study, because the heart rate
hould be 60 beats/min for imaging. Finally, there is the
horny issue of incidental findings. Such incidental findings,
stimated to occur in 5% to 50% of studies, may or may not
e important, but can take a toll on patients.
Unquestionably, imaging tests such as CT and MR
rovide pictures that generally are accurate and, some would
ay, beautiful. As physicians, however, our goal is to help
eople feel better and to live longer, and information is
elpful only to the extent that it furthers this goal. Although
hysicians may disagree about the extent of our responsi-
ility (and ability) to control health care expenses—a subject
or another debate—we can at least distinguish between
rocedures that provide useful additive information and
hose that do not.
We now need to put this additional information into the
ider context of outcomes. Key questions to be asked and
nswered before adopting widespread use of CTA (or any
ew technology) include: 1) What is the incremental value
f the information from this new test compared with
xisting standard assessments (such as office evaluation and
isk factor assessment or stress imaging)? 2) What incre-
ental information is offered by this new test? 3) How will
he incremental information lead to a change in treatment?
nd finally, 4) Will the change in treatment, based on this
est, lead to better patient outcomes? Until we answer yes to
he last question, studies of diagnostic accuracy must be
egarded as important first contributions to our understand-
ng of a new technology, but not sufficient to change clinical
are or guidelines.
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May 8, 2007:1827–9 CT AngiographyThe ACC has taken a leadership position in this new
nvironment. The ACC is working hard on steps to ensure
uality imaging (15). The new Appropriateness Initiative
urrently is addressing the optimal use of imaging tests in
ardiology. However, at the 2006 ACC Convocation, Steve
issen advised cardiologists to temper their enthusiasm for
merging technologies such as imaging with judgment:
New imaging modalities give us a clearer picture of the
eart and vascular system than ever before,” Dr. Nissen said.
But what may be useful and beneficial is still evolving. Our
nfatuation with technology can be wonderful, but it is
ostly and must be used appropriately.” It is important that
ardiologists remain in the forefront not only of acquiring
ew information, but also of understanding how to use it to
mprove patient care. Otherwise, we are just paying extra for
retty pictures, without getting patient benefit.
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